← All Sponsors
SPONSOR

Rigel Pharmaceuticals

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: High Grade GliomaAstrocytomaAstrocytoma, Grade IIIAstrocytoma, Grade IVDiffuse Intrinsic Pontine GliomaWHO Grade III GliomaWHO Grade IV GliomaMetastatic Brain TumorDiffuse Midline Glioma, H3 K27M-MutantThalamus Tumor
NCT06161974 Phase 2
Recruiting

Study of Olutasidenib and Temozolomide in HGG

High Grade Glioma
United States, Australia, Canada View Trial →